Semaphorins and their receptors in pancreatic cancer: Mechanisms and therapeutic opportunities
Frontiers in Oncology · 13.01.2023 · 12
DOI: 10.3389/fonc.2022.1106762 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 13.01.2023. Verfasst von Dahai Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Foshan University, Foshan, Guangdong, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Guangdong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Pancreatic cancer (PC) is a malignant tumor with high malignancy that is difficult to diagnose and treat. PC is a major medical problem because of its low early diagnosis rate, high surgical mortality rate, low cure rate, and expensive related testing cost. Therefore, the significance of finding new markers for PC is self-evident. Semaphorins (Semas) have been shown to affect angiogenesis and lymphangiogenesis and can also directly affect the behavior of tumor cells. The expression and related action targets of its family members on PC are summarized in this review.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, Foshan University, Foshan, Guangdong, China.
- Department of Pulmonary and Critical Care Medicine, Peking University Shenzhen Hospital, Shenzhen, China.
- Department of Pediatric Hematology and Oncology, Children's Hospital of Chongqing Medical University, Chongqing, China.
- Laboratory for Excellence in Systems Biomedicine of Pediatric Oncology, Chongqing Key Laboratory of Pediatrics, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center…
Förderung
- Natural Science Foundation of Guangdong Province
- National Natural Science Foundation of China
Zitieren
APA
Liu, D., Li, J., Qi, F., & You, H. (2023). Semaphorins and their receptors in pancreatic cancer: Mechanisms and therapeutic opportunities. Frontiers in Oncology, 12. https://doi.org/10.3389/fonc.2022.1106762
Vancouver
Liu D, Li J, Qi F, You H. Semaphorins and their receptors in pancreatic cancer: Mechanisms and therapeutic opportunities. Frontiers in Oncology. 2023;12. doi:10.3389/fonc.2022.1106762
BibTeX
@article{Liu2023,
author = {Liu, Dahai and Li, Jie and Qi, Fei and You, Hua},
title = {Semaphorins and their receptors in pancreatic cancer: Mechanisms and therapeutic opportunities},
journal = {Frontiers in Oncology},
year = {2023},
volume = {12},
doi = {10.3389/fonc.2022.1106762}
}
EUVIMED